Founded by an MIT/Harvard alum, Nanobiosym Inc is a medical diagnostics company, creating nanotech solutions for biomedical applications. Nanotechnology stems from the ability to probe and control matter at increasingly finer scales. This ability to control nature at very small scales has profound implications on a variety of industries, ranging from nanomaterials and clean energy to nanomedicine. Nanobiosym was founded to create breakthrough scientific insights and revolutionary technologies that emerge from the convergence of physics, nanotechnology, and biomedicine. Nanobiosym (NBS) works symbiotically with our commercial partner Nanobiosym® Diagnostics (NBSDx) to discover, develop, and commercialize breakthrough technologies at this interface. NBSDx is currently developing nanobiotechnology platforms that address global healthcare needs.